Disruptive Therapeutics.
Advancing Science.
Making a Difference.

SBP-101

Sun BioPharma’s Presentation at the 2017 Marcum MicroCap Conference

Thursday June 15 at 2:30 PM (ET)

*The live webcast will be archived and available to view for 90 days following the conference.
Developing Disruptive Therapeutics for the Treatment of Pancreatic Diseases

Compelling preclinical study results

Preclinical studies have shown that SBP-101 produces superior anti-tumor activity in human cancer cell lines compared to gemcitabine or nab-paclitaxel, alone or in combination, standard of care chemotherapy drugs used to treat pancreatic cancer.

Sun BioPharma’s novel approach

The Company believes that SBP-101 will have a distinct advantage over current pancreatic cancer* therapies in that it specifically targets the exocrine pancreas and can cause ablation, or pharmaceutical resection, of the acinar cells, as well as the primary and metastatic pancreatic cancer, while leaving the insulin-producing islet cells and most non-pancreatic tissue unharmed.  Most current cancer therapies (including chemotherapy, radiation or surgery) are associated with significant side effects that further reduce the patient’s quality of life. Read More »
*pancreatic ductal adenocarcinoma

Compound & Clinical Targets

home1

SBP-101

Read more

pancreatic cancer

Pancreatic Cancer

Read more

home3

Pancreatitis

Read more

Leadership

David Kaysen

President and Chief Executive Officer

Read more

Scott Kellen

Vice President and Chief Financial Officer

Read more

Michael Walker, M.D.

Director of Pancreatic Research

Read more

Michael Cullen, MD

Executive Chairman of the Board

Read more

Thomas Neenan, Ph.D.

Chief Scientific Officer

Read more

Tammy Groene

VP of Operations

Read more

Suzanne Gagnon, MD

Chief Medical Officer

Read more

Ajit Shah, Ph.D.

VP Pharmacology

Read more

Andy Kiorpes, Ph.D.

Toxicology Consultant

Read more

Collaborations

  • adelaide
    Adelaide Cancer Centre
  • Cedarssinai
    Cedars-Sinai Medical Center
  • Charles River Labs
    Charles River
  • cnio1
    CNIO
  • University_of_Florida_logo1
    University of Florida
  • mayo
    Mayo Clinic Scottsdale
  • Minnesota
    University of Minnesota
  • Moffitt Logo1
    Moffitt Cancer Center
  • OSU_James_small2
    Ohio State James Cancer Center